Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 4,398,706 shares, a decline of 62.9% from the February 26th total of 11,868,383 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Genomma Lab Internacional Stock Performance

Shares of OTCMKTS GNMLF remained flat at $1.00 during midday trading on Friday. The company’s 50-day simple moving average is $1.01 and its 200-day simple moving average is $1.03. Genomma Lab Internacional has a 12 month low of $0.93 and a 12 month high of $1.43.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.